Semiconductors
Compare Stocks
5 / 10Stock Comparison
IPGP vs AMAT vs MKSI vs ONTO vs LRCX
Revenue, margins, valuation, and 5-year total return — side by side.
Semiconductors
Hardware, Equipment & Parts
Semiconductors
Semiconductors
IPGP vs AMAT vs MKSI vs ONTO vs LRCX — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Semiconductors | Semiconductors | Hardware, Equipment & Parts | Semiconductors | Semiconductors |
| Market Cap | $4.31B | $325.54B | $20.25B | $13.63B | $357.66B |
| Revenue (TTM) | $1.04B | $28.37B | $4.07B | $1.03B | $21.68B |
| Net Income (TTM) | $29M | $7.00B | $327M | $106M | $6.71B |
| Gross Margin | 37.6% | 48.7% | 45.2% | 48.8% | 50.0% |
| Operating Margin | 0.3% | 29.2% | 14.8% | 10.0% | 34.3% |
| Forward P/E | 62.6x | 37.1x | 30.4x | 38.7x | 50.7x |
| Total Debt | $0.00 | $6.55B | $4.69B | $17M | $4.76B |
| Cash & Equiv. | $404M | $7.24B | $675M | $346M | $6.39B |
IPGP vs AMAT vs MKSI vs ONTO vs LRCX — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| IPG Photonics Corpo… (IPGP) | 100 | 65.4 | -34.6% |
| Applied Materials, … (AMAT) | 100 | 730.7 | +630.7% |
| MKS Inc. (MKSI) | 100 | 284.8 | +184.8% |
| Onto Innovation Inc. (ONTO) | 100 | 881.7 | +781.7% |
| Lam Research Corpor… (LRCX) | 100 | 1046.4 | +946.4% |
Price return only. Dividends and distributions are not included.
Quick Verdict: IPGP vs AMAT vs MKSI vs ONTO vs LRCX
Each card shows where this stock fits in a portfolio — not just who wins on paper.
IPGP ranks third and is worth considering specifically for sleep-well-at-night.
- Lower volatility, beta 1.80, current ratio 6.08x
- Beta 1.80 vs ONTO's 2.66
AMAT is the clearest fit if your priority is income & stability and defensive.
- Dividend streak 8 yrs, beta 2.14, yield 0.4%
- Beta 2.14, yield 0.4%, current ratio 2.61x
- 0.4% yield, 8-year raise streak, vs LRCX's 0.3%, (2 stocks pay no dividend)
MKSI is the #2 pick in this set and the best alternative if growth exposure is your priority.
- Rev growth 9.6%, EPS growth 55.5%, 3Y rev CAGR 3.5%
- Lower P/E (30.4x vs 50.7x)
- +306.1% vs IPGP's +75.6%
ONTO is the clearest fit if your priority is valuation efficiency.
- PEG 1.12 vs LRCX's 2.26
LRCX carries the broadest edge in this set and is the clearest fit for long-term compounding.
- 38.2% 10Y total return vs AMAT's 20.1%
- 23.7% revenue growth vs ONTO's 1.8%
- 30.9% margin vs IPGP's 2.8%
- 31.4% ROA vs IPGP's 1.2%, ROIC 55.7% vs 0.6%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 23.7% revenue growth vs ONTO's 1.8% | |
| Value | Lower P/E (30.4x vs 50.7x) | |
| Quality / Margins | 30.9% margin vs IPGP's 2.8% | |
| Stability / Safety | Beta 1.80 vs ONTO's 2.66 | |
| Dividends | 0.4% yield, 8-year raise streak, vs LRCX's 0.3%, (2 stocks pay no dividend) | |
| Momentum (1Y) | +306.1% vs IPGP's +75.6% | |
| Efficiency (ROA) | 31.4% ROA vs IPGP's 1.2%, ROIC 55.7% vs 0.6% |
IPGP vs AMAT vs MKSI vs ONTO vs LRCX — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
IPGP vs AMAT vs MKSI vs ONTO vs LRCX — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
LRCX leads in 3 of 6 categories
MKSI leads 1 • IPGP leads 0 • AMAT leads 0 • ONTO leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
LRCX leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
AMAT is the larger business by revenue, generating $28.4B annually — 27.5x ONTO's $1.0B. LRCX is the more profitable business, keeping 30.9% of every revenue dollar as net income compared to IPGP's 2.8%. On growth, LRCX holds the edge at +23.8% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $1.0B | $28.4B | $4.1B | $1.0B | $21.7B |
| EBITDAEarnings before interest/tax | $55M | $8.4B | $945M | $158M | $7.8B |
| Net IncomeAfter-tax profit | $29M | $7.0B | $327M | $106M | $6.7B |
| Free Cash FlowCash after capex | $8M | $5.7B | $401M | $239M | $6.5B |
| Gross MarginGross profit ÷ Revenue | +37.6% | +48.7% | +45.2% | +48.8% | +50.0% |
| Operating MarginEBIT ÷ Revenue | +0.3% | +29.2% | +14.8% | +10.0% | +34.3% |
| Net MarginNet income ÷ Revenue | +2.8% | +24.7% | +8.0% | +10.3% | +30.9% |
| FCF MarginFCF ÷ Revenue | +0.8% | +20.1% | +9.8% | +23.2% | +29.8% |
| Rev. Growth (YoY)Latest quarter vs prior year | +16.6% | -3.5% | +15.2% | +9.5% | +23.8% |
| EPS Growth (YoY)Latest quarter vs prior year | -54.4% | +13.9% | +53.2% | -48.5% | +40.8% |
Valuation Metrics
MKSI leads this category, winning 3 of 7 comparable metrics.
Valuation Metrics
At 47.4x trailing earnings, AMAT trades at a 66% valuation discount to IPGP's 139.2x P/E. Adjusting for growth (PEG ratio), AMAT offers better value at 2.76x vs LRCX's 3.08x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $4.3B | $325.5B | $20.2B | $13.6B | $357.7B |
| Enterprise ValueMkt cap + debt − cash | $3.9B | $324.9B | $24.3B | $13.3B | $356.0B |
| Trailing P/EPrice ÷ TTM EPS | 139.22x | 47.40x | 68.83x | 98.57x | 69.01x |
| Forward P/EPrice ÷ next-FY EPS est. | 62.62x | 37.07x | 30.36x | 38.74x | 50.65x |
| PEG RatioP/E ÷ EPS growth rate | — | 2.76x | — | 2.85x | 3.08x |
| EV / EBITDAEnterprise value multiple | 48.90x | 38.68x | 26.70x | 68.79x | 56.63x |
| Price / SalesMarket cap ÷ Revenue | 4.30x | 11.48x | 5.15x | 13.56x | 19.40x |
| Price / BookPrice ÷ Book value/share | 2.04x | 16.25x | 7.49x | 6.43x | 37.47x |
| Price / FCFMarket cap ÷ FCF | — | 57.13x | 40.74x | 45.47x | 66.06x |
Profitability & Efficiency
LRCX leads this category, winning 7 of 9 comparable metrics.
Profitability & Efficiency
LRCX delivers a 65.8% return on equity — every $100 of shareholder capital generates $66 in annual profit, vs $1 for IPGP. ONTO carries lower financial leverage with a 0.01x debt-to-equity ratio, signaling a more conservative balance sheet compared to MKSI's 1.73x. On the Piotroski fundamental quality scale (0–9), LRCX scores 8/9 vs ONTO's 4/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +1.4% | +34.3% | +12.2% | +5.2% | +65.8% |
| ROA (TTM)Return on assets | +1.2% | +19.3% | +3.7% | +4.7% | +31.4% |
| ROICReturn on invested capital | +0.6% | +33.3% | +6.5% | +5.7% | +55.7% |
| ROCEReturn on capital employed | +0.6% | +30.6% | +7.2% | +6.5% | +40.4% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 7 | 6 | 4 | 8 |
| Debt / EquityFinancial leverage | — | 0.32x | 1.73x | 0.01x | 0.48x |
| Net DebtTotal debt minus cash | -$404M | -$686M | $4.0B | -$329M | -$1.6B |
| Cash & Equiv.Liquid assets | $404M | $7.2B | $675M | $346M | $6.4B |
| Total DebtShort + long-term debt | $0 | $6.6B | $4.7B | $17M | $4.8B |
| Interest CoverageEBIT ÷ Interest expense | — | 35.46x | 2.84x | — | 58.92x |
Total Returns (Dividends Reinvested)
LRCX leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in LRCX five years ago would be worth $46,048 today (with dividends reinvested), compared to $5,151 for IPGP. Over the past 12 months, MKSI leads with a +306.1% total return vs IPGP's +75.6%. The 3-year compound annual growth rate (CAGR) favors LRCX at 76.4% vs IPGP's -4.4% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +35.8% | +52.9% | +78.8% | +65.2% | +54.9% |
| 1-Year ReturnPast 12 months | +75.6% | +164.7% | +306.1% | +118.9% | +282.9% |
| 3-Year ReturnCumulative with dividends | -12.7% | +258.7% | +266.0% | +218.0% | +448.8% |
| 5-Year ReturnCumulative with dividends | -48.5% | +213.8% | +66.5% | +312.6% | +360.5% |
| 10-Year ReturnCumulative with dividends | +20.2% | +2014.4% | +750.6% | +1431.7% | +3815.1% |
| CAGR (3Y)Annualised 3-year return | -4.4% | +53.1% | +54.1% | +47.1% | +76.4% |
Risk & Volatility
Evenly matched — IPGP and LRCX each lead in 1 of 2 comparable metrics.
Risk & Volatility
IPGP is the less volatile stock with a 1.80 beta — it tends to amplify market swings less than ONTO's 2.66 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. LRCX currently trades 96.1% from its 52-week high vs IPGP's 65.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.80x | 2.14x | 2.64x | 2.66x | 2.54x |
| 52-Week HighHighest price in past year | $155.82 | $432.81 | $326.83 | $315.86 | $298.00 |
| 52-Week LowLowest price in past year | $53.98 | $151.51 | $71.49 | $85.88 | $72.91 |
| % of 52W HighCurrent price vs 52-week peak | +65.2% | +94.8% | +92.0% | +86.8% | +96.1% |
| RSI (14)Momentum oscillator 0–100 | 39.7 | 66.3 | 65.3 | 61.0 | 69.9 |
| Avg Volume (50D)Average daily shares traded | 510K | 6.0M | 1.2M | 832K | 9.7M |
Analyst Outlook
Evenly matched — AMAT and LRCX each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: IPGP as "Buy", AMAT as "Buy", MKSI as "Buy", ONTO as "Buy", LRCX as "Buy". Consensus price targets imply 49.2% upside for IPGP (target: $152) vs -9.3% for MKSI (target: $273). For income investors, AMAT offers the higher dividend yield at 0.42% vs MKSI's 0.29%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | $151.67 | $426.39 | $272.86 | $308.33 | $290.65 |
| # AnalystsCovering analysts | 27 | 53 | 29 | 11 | 50 |
| Dividend YieldAnnual dividend ÷ price | — | +0.4% | +0.3% | — | +0.3% |
| Dividend StreakConsecutive years of raises | 1 | 8 | 0 | — | 11 |
| Dividend / ShareAnnual DPS | — | $1.71 | $0.87 | — | $0.89 |
| Buyback YieldShare repurchases ÷ mkt cap | +1.3% | +1.5% | +0.2% | +0.6% | +1.0% |
LRCX leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). MKSI leads in 1 (Valuation Metrics). 2 tied.
IPGP vs AMAT vs MKSI vs ONTO vs LRCX: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is IPGP or AMAT or MKSI or ONTO or LRCX a better buy right now?
For growth investors, Lam Research Corporation (LRCX) is the stronger pick with 23.
7% revenue growth year-over-year, versus 1. 8% for Onto Innovation Inc. (ONTO). Applied Materials, Inc. (AMAT) offers the better valuation at 47. 4x trailing P/E (37. 1x forward), making it the more compelling value choice. Analysts rate IPG Photonics Corporation (IPGP) a "Buy" — based on 27 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — IPGP or AMAT or MKSI or ONTO or LRCX?
On trailing P/E, Applied Materials, Inc.
(AMAT) is the cheapest at 47. 4x versus IPG Photonics Corporation at 139. 2x. On forward P/E, MKS Inc. is actually cheaper at 30. 4x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Onto Innovation Inc. wins at 1. 12x versus Lam Research Corporation's 2. 26x — a reasonable growth-adjusted valuation.
03Which is the better long-term investment — IPGP or AMAT or MKSI or ONTO or LRCX?
Over the past 5 years, Lam Research Corporation (LRCX) delivered a total return of +360.
5%, compared to -48. 5% for IPG Photonics Corporation (IPGP). Over 10 years, the gap is even starker: LRCX returned +38. 2% versus IPGP's +20. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — IPGP or AMAT or MKSI or ONTO or LRCX?
By beta (market sensitivity over 5 years), IPG Photonics Corporation (IPGP) is the lower-risk stock at 1.
80β versus Onto Innovation Inc. 's 2. 66β — meaning ONTO is approximately 48% more volatile than IPGP relative to the S&P 500. On balance sheet safety, Onto Innovation Inc. (ONTO) carries a lower debt/equity ratio of 1% versus 173% for MKS Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — IPGP or AMAT or MKSI or ONTO or LRCX?
By revenue growth (latest reported year), Lam Research Corporation (LRCX) is pulling ahead at 23.
7% versus 1. 8% for Onto Innovation Inc. (ONTO). On earnings-per-share growth, the picture is similar: IPG Photonics Corporation grew EPS 117. 8% year-over-year, compared to -31. 5% for Onto Innovation Inc.. Over a 3-year CAGR, MKSI leads at 3. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — IPGP or AMAT or MKSI or ONTO or LRCX?
Lam Research Corporation (LRCX) is the more profitable company, earning 29.
1% net margin versus 3. 1% for IPG Photonics Corporation — meaning it keeps 29. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: LRCX leads at 32. 0% versus 1. 3% for IPGP. At the gross margin level — before operating expenses — ONTO leads at 49. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is IPGP or AMAT or MKSI or ONTO or LRCX more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Onto Innovation Inc. (ONTO) is the more undervalued stock at a PEG of 1. 12x versus Lam Research Corporation's 2. 26x. A PEG below 1. 5 suggests fair-to-attractive pricing relative to expected growth. On forward earnings alone, MKS Inc. (MKSI) trades at 30. 4x forward P/E versus 62. 6x for IPG Photonics Corporation — 32. 3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for IPGP: 49. 2% to $151. 67.
08Which pays a better dividend — IPGP or AMAT or MKSI or ONTO or LRCX?
In this comparison, AMAT (0.
4% yield), LRCX (0. 3% yield), MKSI (0. 3% yield) pay a dividend. IPGP, ONTO do not pay a meaningful dividend and should not be held primarily for income.
09Is IPGP or AMAT or MKSI or ONTO or LRCX better for a retirement portfolio?
For long-horizon retirement investors, Onto Innovation Inc.
(ONTO) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (+1432% 10Y return). Applied Materials, Inc. (AMAT) carries a higher beta of 2. 14 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (ONTO: +1432%, AMAT: +20. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between IPGP and AMAT and MKSI and ONTO and LRCX?
Both stocks operate in the Technology sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: IPGP is a small-cap quality compounder stock; AMAT is a large-cap quality compounder stock; MKSI is a mid-cap quality compounder stock; ONTO is a mid-cap quality compounder stock; LRCX is a large-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.